The inverse relationship between INHBA and hsa-miR-375 in our study suggests that restoring the levels of hsa-miR-375 could potentially suppress INHBA activity, offering a therapeutic approach to inhibit tumor progression in colon cancer. Here, INHBA is linked to malignant colon neoplasm.